Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. April 2026 09:30 ET | Quelle: Mapi Pharma

Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026

NESS ZIONA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting...
16. April 2026 09:05 ET | Quelle: Progyny, Inc.

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

Progyny announces first-of-its-kind plan that expands access to comprehensive fertility benefits with predictable costs for small employers
16. April 2026 09:00 ET | Quelle: Fate Therapeutics, Inc.

Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annual Meeting

SAN DIEGO, April 16, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...
16. April 2026 09:00 ET | Quelle: Tiny Health

Nearly 4 in 10 women are missing vaginal bacteria linked to fertility

Tiny Health found that 39% of women sampling their vaginal microbiome had low or absent Lactobacillus levels, a key bacteria linked to fertility outcomes.
16. April 2026 09:00 ET | Quelle: Muscular Dystrophy Association

Retailers Nationwide Partner with Muscular Dystrophy Association to Send Hundreds of Young People to Life-Changing Summer Camp

New York, April 16, 2026 (GLOBE NEWSWIRE) -- This summer, shoppers across the U.S. can make a lasting impact for kids and young adults living with neuromuscular diseases. The Muscular Dystrophy...
16. April 2026 09:00 ET | Quelle: Royal Philips

Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications

April 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology ...
16. April 2026 08:53 ET | Quelle: Achieve Life Sciences

Achieve Life Sciences Announces Up to $354 Million Private Placement

$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations,...
16. April 2026 08:45 ET | Quelle: International Myeloma Foundation

Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research

STUDIO CITY, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announces its 3rd annual Iceland Cycling Expedition, taking place August 18-24, 2026, where...
16. April 2026 08:35 ET | Quelle: NANO-X IMAGING LTD

Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design

International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings PETACH TIKVA, ISRAEL - 16 April, 2026 -...
16. April 2026 07:30 ET | Quelle: Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026

Vorherige Seite

Nächste Seite